Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 4,706 Jan 1 – Oct 25, 2026
- Disclosed funding
- $339.7B 3667 disclosed amounts
- Median round
- $14.5M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| L LittlebirdCompany profile Develops an AI assistant that continuously understands screen and meetings to deliver answers Develops an AI assistant that continuously understands screen and meetings to deliver answers | $11M | Seed | AI | United States | Investors | |
| N Develops AI-powered mobility platform for traffic management | $90M | Series CSeries C+ | Mobility | United States | Investors | |
| KC Karpel Computer SystemsCompany profile Provides case management system software for prosecutor and public defender offices nationwide Provides case management system software for prosecutor and public defender offices nationwide | Undisclosed | Growth | Enterprise software | United States | Investors | |
| VI Vitamin°C I FundCompany profile Vitamin°C I Fund backs young companies developing climate mitigation and adaptation technologies. Vitamin°C I Fund backs young companies developing climate mitigation and adaptation technologies. | €18M | Fund I first closeUndisclosed | Business services | Luxembourg | Investors Undisclosed | |
| D DoctronicCompany profile Provides AI-powered personalized health insights and connects users to licensed providers instantly Provides AI-powered personalized health insights and connects users to licensed providers instantly | $40M | Series B | Healthtech | United States | Investors | |
| Z Provides AI-powered agents to ease manual workload of finance teams | $3.6M | Seed | Fintech | United Kingdom | Investors | |
 NanoZymeXCompany profile NanoZymeX develops a lipid-nanoparticle platform for enzyme replacement therapy. NanoZymeX develops a lipid-nanoparticle platform for enzyme replacement therapy. | €160K | Pre-SeedPre-seed | Biotech | Switzerland | Investors | |
| ET Develops novel therapies for beta globin disorders | $32M | GrantUndisclosed | Biotech | United States | Investors | |
 NopaleraCompany profile Nopalera offers beauty and lifestyle products, including fragrances, hair care, and bath and body products. Nopalera offers beauty and lifestyle products, including fragrances, hair care, and bath and body products. | $4M | Seed | Ecommerce | United States | Investors | |
| S SpadeCompany profile Data and AI platform transforming how financial institutions use transaction data Data and AI platform transforming how financial institutions use transaction data | $40M | Series B | Fintech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
BioStack, Tractian, Blacksmith
161rounds5led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
111rounds21led - 3General Catalyst
Tractian, Legora, Different
100rounds12led - 4Lightspeed
Warp Sciences, Different, Zenzap
80rounds9led - 5Sequoia Capital
Warhound, Whop, Blacksmith
71rounds13led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →